Cancer Moonshot℠ - Funding by Research Category

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

To ensure the Cancer Moonshot goals and approaches were grounded in the best science, NCI convened a Blue Ribbon Panel (BRP) of scientific experts as a working group to the National Cancer Advisory board. In September of 2016, the BRP presented a final report outlining 10 research recommendations that represent areas that are well-positioned to accelerate progress in cancer prevention, diagnosis, treatment and care.

Download Table Data

The following research categories align with these 10 recommendations:

Cancer Moonshot by Category, FY 2017
(Whole Dollars)
Research Category Amount
Network for Direct Patient Engagement     $19,999,626
Cancer Immunotherapy Translational Science Network     $34,011,598
Therapeutic Target Identification to Overcome Drug Resistance    


A National Cancer Data Ecosystem for Sharing and Analysis    


Fusion Oncoproteins in Childhood Cancers    


Prevention and early detection: Implementation of Evidence-Based Approaches


Retrospective Analysis of Biospecimens form Patients Treated with Standard of Care


Generation of Human Tumor Atlases


Development of New Enabling Cancer Technologies


Other Cancer Moonshot priority activities (e.g., Partnership for Accelerating Cancer Therapies)


Subtotal, Research Category


Fiscal Year 2017 Carryover



  • Posted: February 16, 2018